Mark T Iwicki has an estimated net worth of $8.98 Million. This is based on reported shares across multiple companies, which include Merus N.V., Pulmatrix, Inc., Aerovate Therapeutics, Inc., Akero Therapeutics, Inc., KALA BIO, Inc., Aimmune Therapeutics, Inc., Third Harmonic Bio, Inc., SEPRACOR INC /DE/, Q32 Bio Inc., and Inhibikase Therapeutics, Inc..

2025 was Mark T Iwicki's most active year for acquiring shares with 15 total transactions. Mark T Iwicki's most active month to acquire stocks was the month of May. 2025 was Mark T Iwicki's most active year for disposing of shares, totalling 28 transactions. Mark T Iwicki's most active month to dispose stocks was the month of November. 2007 saw Mark T Iwicki paying a total of $5,724,700.00 for 230,000 shares, this is the most they've acquired in one year. In 2025 Mark T Iwicki cashed out on 877,284 shares for a total of $7,400,109.02, their largest year based on trade value.